Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides

Details for Australian Patent Application No. 2005223492 (hide)

Owner Institut Pasteur

Inventors Huaulme, Jean-Francois; Ungeheuer, Marie-Noelle; Wisner, Anne; Rougeot, Catherine; Dufour, Evelyne

Agent Davies Collison Cave

Pub. Number AU-B-2005223492

PCT Pub. Number WO2005/090386

Priority 04290754.3 19.03.04 EP

Filing date 18 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 26 May 2011

International Classifications

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C07K 5/083 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/113 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/090386 Priority application(s): WO2005/090386

26 May 2011 Application Accepted

  Published as AU-B-2005223492

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005223495-Gasification of carbonaceous material

2005223491-Crystalline form of atorvastatin hemi calcium